App improves survival of advanced cancer patients by 5 months

Cara Livernois | | Health Exec | Precision Medicine

Ethan Basch, MD, has developed a web-based tool for cancer patients to report symptoms on a weekly basis. The Symptom Tracking And Reporting (STAR) tool aims to improve quality of life and reduce emergency room visits for patients with advanced cancers.

In studies on the app, researchers were able to increase the survival of 766 patients with advanced urologic, gynecologic, breast or lung cancer by an average of five months.

“This tool brings us closer to the country doctor model,” Basch said. “We’re in touch with our patients on a regular basis, he said. “As an oncologist, it makes me feel like my patients aren’t ‘out of sight and out of mind.’ When my patients are using this tool, I worry less that they’re going to experience something and I won’t know about it,” he said. “If patients are experiencing a problem, we can reach out.”

Read the full story below:

The Paradoxical Benefits Of A Web App For Cancer Patients

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.